ReviewReviews in endocrine & metabolic disorders2022

Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes.

Manoj Kumar Mahapatra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.